Catalyzed by the pandemic, the pharma industry quickly progressed from being digitally agnostic to a state of preparedness. The shift required the industry to experiment with technology in its customer-facing plans, which resulted in many cases the creation of random acts of digital, often without a cohesive overarching strategy. Can pharma do better? The answer lies in understanding the utility of their digital assets while building a mindset to transform, and ensuring that teams within the organization do not work at cross-purposes.

Independence Day Special issue with Vivek Hattangadi tracing the India pharma brand story from before Independence till today.

The pill is now a commodity that many of these companies provide at heavy discounts, making money off everything ‘beyond the pill’. Investors are betting heavily on the potential of technological innovation to transform the way healthcare is delivered. The Economic Times reported that in 2021, India recorded investments of $77 billion across 1,266 deals including 164 large deals worth $58 billion. While the money reduced in 2022, the reason wasn’t a lack of faith in this business model. Meanwhile, the pharmaceuticals industry that is most affected by this quiet but rapid change, is grappling with its entrenched culture. Its current business is so profitable that everything else pales in comparison. ‘Build, measure, learn, build again’ – a mantra of the health tech industry is alien to pharma that doesn’t learn, build or measure after launching a product. Pharma also thinks of its customers as doctors alone and does precious little to connect with patients, or caregivers. People who are not sick do not feature on their radar at all. These are cultural values that keep pharma focused on the pill and discourage thinking beyond it. A social media poll conducted by MedicinMan showed almost predictable responses. 100+ respondents who work in the pharma industry in India were quite clearly divided. 48% of them wanted to know what beyond the pill actually meant, while 23% wanted to know how to execute it. The rest felt that the ultra-competitive environment in the Indian generics market required very high share-of-voice tactics (19%), or that their customers demanded product information (9%).

In our rapidly changing world, adaptability is essential. The strategies and decisions that yielded results yesterday might not be as effective today. By actively engaging with and updating our mental models, we position ourselves to adapt swiftly to evolving circumstances. This ensures our decisions remain timely and anchored in the present.

With the Second Wave hitting India, customers (patients and physicians) will continue to socially distance themselves in the foreseeable future. Pharma must use the field force for reach and relationship and digital for frequency and personalised content for better customer experience. The pandemic has made doctors adopt Telehealth in a substantial way to shore up their revenues and this will continue to be one of their channels to engage patients. Telehealth along with EMR/EHR, digital therapeutics and wearables is enabling doctors to better care for their patients. There are many ways in which pharma can support the digital evolution of doctors.

The future in your palm - a non-contact wearable...

Nimesulide Regulatory Status Worldwide Nimesulide is a non-steroidal anti-inflammatory drug...

Indian Pharma Top Brands, Therapy & Regional Insights ...

April 14, 2025  India’s pharmaceutical industry, a global powerhouse, sends...

The pharmaceutical market in 2024 saw major shifts driven...

The future in your palm - a non-contact wearable...

Nimesulide Regulatory Status Worldwide Nimesulide is a non-steroidal anti-inflammatory drug...

Indian Pharma Top Brands, Therapy & Regional Insights ...

April 14, 2025  India’s pharmaceutical industry, a global powerhouse, sends...

The pharmaceutical market in 2024 saw major shifts driven...

The future in your palm - a non-contact wearable...

Nimesulide Regulatory Status Worldwide Nimesulide is a non-steroidal anti-inflammatory drug...

Indian Pharma Top Brands, Therapy & Regional Insights ...

April 14, 2025  India’s pharmaceutical industry, a global powerhouse, sends...

The pharmaceutical market in 2024 saw major shifts driven...

The future in your palm - a non-contact wearable...

Nimesulide Regulatory Status Worldwide Nimesulide is a non-steroidal anti-inflammatory drug...

Indian Pharma Top Brands, Therapy & Regional Insights ...

April 14, 2025  India’s pharmaceutical industry, a global powerhouse, sends...

The pharmaceutical market in 2024 saw major shifts driven...

With the Second Wave hitting India, customers (patients and physicians) will continue to socially distance themselves in the foreseeable future. Pharma must use the field force for reach and relationship and digital for frequency and personalised content for better customer experience. The pandemic has made doctors adopt Telehealth in a substantial way to shore up their revenues and this will continue to be one of their channels to engage patients. Telehealth along with EMR/EHR, digital therapeutics and wearables is enabling doctors to better care for their patients. There are many ways in which pharma can support the digital evolution of doctors.

Analysis of Indian Pharmaceutical Market (IPM) – 2024 This data...

The Medical department comprising of Clinical Operations (the ones...

KKR's Investments in India's Medical Devices Market: Strategic Implications...

Measurement and optimization for digital marketing is one of...

The future in your palm - a non-contact wearable...

Nimesulide Regulatory Status Worldwide Nimesulide is a non-steroidal anti-inflammatory drug...

Indian Pharma Top Brands, Therapy & Regional Insights ...

April 14, 2025  India’s pharmaceutical industry, a global powerhouse, sends...

The pharmaceutical market in 2024 saw major shifts driven...

The future in your palm - a non-contact wearable...

Nimesulide Regulatory Status Worldwide Nimesulide is a non-steroidal anti-inflammatory drug...

Indian Pharma Top Brands, Therapy & Regional Insights ...

April 14, 2025  India’s pharmaceutical industry, a global powerhouse, sends...

The pharmaceutical market in 2024 saw major shifts driven...

The future in your palm - a non-contact wearable...

Nimesulide Regulatory Status Worldwide Nimesulide is a non-steroidal anti-inflammatory drug...

Indian Pharma Top Brands, Therapy & Regional Insights ...

April 14, 2025  India’s pharmaceutical industry, a global powerhouse, sends...

The pharmaceutical market in 2024 saw major shifts driven...

The future in your palm - a non-contact wearable...

Nimesulide Regulatory Status Worldwide Nimesulide is a non-steroidal anti-inflammatory drug...

Indian Pharma Top Brands, Therapy & Regional Insights ...

April 14, 2025  India’s pharmaceutical industry, a global powerhouse, sends...

The pharmaceutical market in 2024 saw major shifts driven...